‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long

A pancreatic cancer drug more than four decades in the making has cracked one of the most stubbornly lethal cancers, extending people’s lives and keeping their tumors in check for twice as long as those on regular chemotherapy. The detailed results of the clinical trial, presented Sunday at a plena...

Redirecting to full article...